Financhill
Buy
61

TRS Quote, Financials, Valuation and Earnings

Last price:
$36.01
Seasonality move :
0.48%
Day range:
$35.21 - $35.92
52-week range:
$19.33 - $40.34
Dividend yield:
0.45%
P/E ratio:
32.96x
P/S ratio:
1.43x
P/B ratio:
1.99x
Volume:
574.9K
Avg. volume:
690.6K
1-year change:
44.16%
Market cap:
$1.4B
Revenue:
$925M
EPS (TTM):
$1.08

Analysts' Opinion

  • Consensus Rating
    TriMas Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $41.50, TriMas Corp. has an estimated upside of 17.07% from its current price of $35.45.
  • Price Target Downside
    According to analysts, the lowest downside price target is $38.00 representing 100% downside risk from its current price of $35.45.

Fair Value

  • According to the consensus of 1 analyst, TriMas Corp. has 17.07% upside to fair value with a price target of $41.50 per share.

TRS vs. S&P 500

  • Over the past 5 trading days, TriMas Corp. has overperformed the S&P 500 by 0.44% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • TriMas Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • TriMas Corp. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter TriMas Corp. reported revenues of $269.3M.

Earnings Growth

  • TriMas Corp. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter TriMas Corp. reported earnings per share of $0.23.
Enterprise value:
1.9B
EV / Invested capital:
--
Price / LTM sales:
1.43x
EV / EBIT:
22.49x
EV / Revenue:
1.84x
PEG ratio (5yr expected):
0.49x
EV / Free cash flow:
41.96x
Price / Operating cash flow:
32.74x
Enterprise value / EBITDA:
12.60x
Gross Profit (TTM):
$218.8M
Return On Assets:
3.16%
Net Income Margin (TTM):
4.35%
Return On Equity:
6.34%
Return On Invested Capital:
3.81%
Operating Margin:
9.2%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $887.3M $906.5M $1B $229.4M $269.3M
Gross Profit $193.6M $190.6M $218.8M $48M $62.1M
Operating Income $69.5M $54.4M $82.8M $7.2M $24.8M
EBITDA $126.4M $111M $147.9M $21.4M $39.3M
Diluted EPS $1.22 $0.64 $1.08 $0.06 $0.23
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $443.4M $416.8M $407.4M $435.3M $483.2M
Total Assets $1.3B $1.3B $1.3B $1.4B $1.4B
Current Liabilities $138.4M $158.5M $157.6M $154M $180.1M
Total Liabilities $643.9M $667.3M $667M $685.1M $708.8M
Total Equity $614.3M $634.6M $675M $682.8M $725M
Total Debt $425.5M $437.2M $437M $449M $445.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $83.5M $67.3M $103M $22M $36.5M
Cash From Investing -$97.3M -$54.5M -$74.7M -$8M -$13.6M
Cash From Financing -$31.9M -$20.6M -$21.6M -$22.1M -$19.5M
Free Cash Flow $34.4M $12.1M $44.4M $10.2M $22.8M
TRS
Sector
Market Cap
$1.4B
$22.5M
Price % of 52-Week High
87.88%
72.97%
Dividend Yield
0.45%
0%
Shareholder Yield
0.89%
-2.79%
1-Year Price Total Return
44.16%
13.1%
Beta (5-Year)
0.574
0.601
Dividend yield:
0.45%
Annualized payout:
$0.16
Payout ratio:
17.68%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $35.67
200-day SMA
Buy
Level $31.35
Bollinger Bands (100)
Sell
Level 33.59 - 38.71
Chaikin Money Flow
Buy
Level 316.9K
20-day SMA
Buy
Level $34.59
Relative Strength Index (RSI14)
Buy
Level 57.84
ADX Line
Buy
Level 31.68
Williams %R
Neutral
Level -31.0345
50-day SMA
Buy
Level $34.34
MACD (12, 26)
Buy
Level 9.82
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Sell
Level -368.7K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.0066)
Buy
CA Score (Annual)
Level (0.0157)
Buy
Beneish M-Score (Annual)
Level (-2.5257)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.3028)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs and manufactures dispensing products, including foaming pumps, lotion and hand soap pumps, sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers, polymeric and steel caps and closures, including food lids, flip-top closures, child resistant caps, drum and pail closures, and flexible spouts, polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, all for a variety of consumer product markets including, but not limited to, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical, as well as the industrial market. The Aerospace segment is involved in the design and manufacture of precision fasteners, tubular products and assemblies for fluid conveyance, and machined products and assemblies to serve the aerospace and defense market under the brand name Monogram Aerospace Fasteners, RSA Engineered Products and Martinic Engineering, Allfast Fastening Systems, and Mac Fasteners. The Specialty Products segment designs, manufactures, and distributes highly-engineered steel cylinders, wellhead engines, and compression systems for use within industrial markets and includes the Norris Cylinder and Arrow Engine brands. The company was founded by Brian P. Campbell in 1986 and is headquartered in Bloomfield Hills, MI.

Stock Forecast FAQ

In the current month, TRS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TRS average analyst price target in the past 3 months is $41.50.

  • Where Will TriMas Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that TriMas Corp. share price will rise to $41.50 per share over the next 12 months.

  • What Do Analysts Say About TriMas Corp.?

    Analysts are divided on their view about TriMas Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that TriMas Corp. is a Sell and believe this share price will drop from its current level to $38.00.

  • What Is TriMas Corp.'s Price Target?

    The price target for TriMas Corp. over the next 1-year time period is forecast to be $41.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is TRS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for TriMas Corp. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of TRS?

    You can purchase shares of TriMas Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase TriMas Corp. shares.

  • What Is The TriMas Corp. Share Price Today?

    TriMas Corp. was last trading at $36.01 per share. This represents the most recent stock quote for TriMas Corp.. Yesterday, TriMas Corp. closed at $35.45 per share.

  • How To Buy TriMas Corp. Stock Online?

    In order to purchase TriMas Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 9.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock